Document Detail

Inhaled iloprost for therapy in pulmonary arterial hypertension.
MedLine Citation:
PMID:  21510725     Owner:  NLM     Status:  In-Data-Review    
Iloprost (Ventavis(®), Bayer Schering Pharma, Germany) is a synthetic prostacyclin that is used in its inhalative form for the therapy of pulmonary arterial hypertension. Long-term therapy can increase exercise capacity and quality of life. The use of modern nebulizers especially designed for the administration of iloprost guarantees the pulmonary deposition of the required doses and systematically minimizes side effects. Regarding existing data, inhalative iloprost acts in effective and safe combination with other classes of medication; indeed, such combination therapy is frequently necessary in pulmonary arterial hypertension.
Ralf Ewert; Sven Gläser; Tom Bollmann; Christoph Schäper
Related Documents :
19444375 - Self-closing nitinol u-clips for intracranial arterial microanastomosis: a preliminary ...
16933385 - Successful management of post-tumor resection middle cerebral artery thrombosis with st...
21223375 - Hemodynamic support with impella 2.5 during balloon aortic valvuloplasty in a high-risk...
9839985 - Virtual cisternoscopy of intracranial vessels: a novel visualization technique using vi...
22754635 - Mitral-aortic intervalvular fibrosa aneurysm with rupture into left atrium: an uncommon...
15227015 - Valvular injuries resulting from blunt chest trauma.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of respiratory medicine     Volume:  5     ISSN:  1747-6356     ISO Abbreviation:  Expert Rev Respir Med     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-04-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101278196     Medline TA:  Expert Rev Respir Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  145-52     Citation Subset:  IM    
Department of Internal Medicine, Ernst-Moritz-Arndt University, Greifswald, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Xanthine oxidase inhibitors: a patent survey.
Next Document:  Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension.